Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-1990 | 07-1990 | 04-1990 | 01-1990 | 10-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 977 | 112 | 107 | 145 | 346 |
| Marketable Securities | 0 | 0 | 0 | 8 | 0 |
| Receivables | 222 | 202 | 215 | 172 | 542 |
| Inventories | 108 | 117 | 130 | 243 | 209 |
| Other current assets | 50 | 56 | 81 | 133 | 66 |
| TOTAL | $1,357 | $487 | $533 | $701 | $1,163 |
| Non-Current Assets | |||||
| PPE Net | 1,895 | 1,877 | 1,877 | 1,902 | 1,662 |
| Other Non-Current Assets | 273 | 319 | 323 | 444 | 307 |
| TOTAL | $2,168 | $2,195 | $2,200 | $2,346 | $1,969 |
| Total Assets | $0 | $2,213 | $2,302 | $2,663 | $2,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 75 | 153 | 220 | 142 | 114 |
| Accounts payable and accrued liabilities | 643 | 560 | 561 | 609 | 410 |
| Accrued Expenses | 206 | 188 | 280 | 279 | 21 |
| Other current liabilities | 243 | 111 | 45 | 20 | 59 |
| TOTAL | $1,991 | $1,607 | $1,701 | $1,125 | $604 |
| Non-Current Liabilities | |||||
| Long Term Debt | 196 | 192 | 192 | 659 | 672 |
| TOTAL | $196 | $192 | $192 | $659 | $672 |
| Total Liabilities | $2,188 | $1,799 | $1,892 | $1,783 | $1,276 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -2,076 | -2,458 | -2,462 | -1,983 | -1,278 |
| TOTAL | $796 | $414 | $410 | $880 | $1,533 |
| Total Liabilities And Equity | $2,983 | $2,213 | $2,302 | $2,663 | $2,810 |